UniProt ID | STRN3_HUMAN | |
---|---|---|
UniProt AC | Q13033 | |
Protein Name | Striatin-3 | |
Gene Name | STRN3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 797 | |
Subcellular Localization |
Cytoplasm. Membrane Peripheral membrane protein. |
|
Protein Description | Binds calmodulin in a calcium dependent manner. May function as scaffolding or signaling protein.. | |
Protein Sequence | MDELAGGGGGGPGMAAPPRQQQGPGGNLGLSPGGNGAAGGGGPPASEGAGPAAGPELSRPQQYTIPGILHYIQHEWARFEMERAHWEVERAELQARIAFLQGERKGQENLKKDLVRRIKMLEYALKQERAKYHKLKYGTELNQGDLKMPTFESEETKDTEAPTAPQNSQLTWKQGRQLLRQYLQEVGYTDTILDVRSQRVRSLLGLSNSEPNGSVETKNLEQILNGGESPKQKGQEIKRSSGDVLETFNFLENADDSDEDEENDMIEGIPEGKDKHRMNKHKIGNEGLAADLTDDPDTEEALKEFDFLVTAEDGEGAGEARSSGDGTEWDKDDLSPTAEVWDVDQGLISKLKEQYKKERKGKKGVKRANRTKLYDMIADLGDDELPHIPSGIINQSRSASTRMTDHEGARAEEAEPITFPSGGGKSFIMGSDDVLLSVLGLGDLADLTVTNDADYSYDLPANKDAFRKTWNPKYTLRSHFDGVRALAFHPVEPVLVTASEDHTLKLWNLQKTVPAKKSASLDVEPIYTFRAHIGPVLSLAISSNGEQCFSGGIDATIQWWNMPSPSVDPYDTYEPNVLAGTLVGHTDAVWGLAYSGIKNQLLSCSADGTVRLWNPQEKLPCICTYNGDKKHGIPTSVDFIGCDPAHMVTSFNTGSAVIYDLETSQSLVILSSQVDSGLQSNNHINRVVSHPTLPVTITAHEDRHIKFFDNKTGKMIHSMVAHLDAVTSLAVDPNGIYLMSGSHDCSIRLWNLDSKTCVQEITAHRKKLDESIYDVAFHSSKAYIASAGADALAKVFV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MDELAGGG -------CCCCCCCC | 9.01 | 22223895 | |
31 | Phosphorylation | PGGNLGLSPGGNGAA CCCCCCCCCCCCCCC | 21.50 | 25850435 | |
46 | Phosphorylation | GGGGPPASEGAGPAA CCCCCCCCCCCCCCC | 42.19 | 25850435 | |
111 | Ubiquitination | RKGQENLKKDLVRRI HHCHHHHHHHHHHHH | 56.68 | 24816145 | |
126 | Ubiquitination | KMLEYALKQERAKYH HHHHHHHHHHHHHHH | 41.77 | 32015554 | |
136 | Acetylation | RAKYHKLKYGTELNQ HHHHHHCCCCCCCCC | 46.57 | 25953088 | |
137 | Phosphorylation | AKYHKLKYGTELNQG HHHHHCCCCCCCCCC | 39.45 | 28152594 | |
139 | Phosphorylation | YHKLKYGTELNQGDL HHHCCCCCCCCCCCC | 33.92 | 28152594 | |
147 | Ubiquitination | ELNQGDLKMPTFESE CCCCCCCCCCCCCCC | 47.80 | 32015554 | |
150 | Phosphorylation | QGDLKMPTFESEETK CCCCCCCCCCCCCCC | 36.21 | 26437602 | |
157 (in isoform 2) | Ubiquitination | - | 66.97 | 21890473 | |
157 (in isoform 1) | Ubiquitination | - | 66.97 | 21890473 | |
157 | Ubiquitination | TFESEETKDTEAPTA CCCCCCCCCCCCCCC | 66.97 | 22817900 | |
163 | Phosphorylation | TKDTEAPTAPQNSQL CCCCCCCCCCCCCCC | 59.00 | 27732954 | |
168 | Phosphorylation | APTAPQNSQLTWKQG CCCCCCCCCCCHHHH | 22.71 | 25850435 | |
171 | Phosphorylation | APQNSQLTWKQGRQL CCCCCCCCHHHHHHH | 23.99 | 30576142 | |
173 | Ubiquitination | QNSQLTWKQGRQLLR CCCCCCHHHHHHHHH | 37.32 | 23000965 | |
173 (in isoform 2) | Ubiquitination | - | 37.32 | 21890473 | |
173 (in isoform 1) | Ubiquitination | - | 37.32 | 21890473 | |
202 | Phosphorylation | VRSQRVRSLLGLSNS HHHHHHHHHHCCCCC | 25.70 | 30266825 | |
207 | Phosphorylation | VRSLLGLSNSEPNGS HHHHHCCCCCCCCCC | 36.19 | 30266825 | |
209 | Phosphorylation | SLLGLSNSEPNGSVE HHHCCCCCCCCCCCC | 51.56 | 30266825 | |
214 | Phosphorylation | SNSEPNGSVETKNLE CCCCCCCCCCCCCHH | 24.34 | 21815630 | |
217 | Phosphorylation | EPNGSVETKNLEQIL CCCCCCCCCCHHHHH | 24.07 | 23403867 | |
229 | Phosphorylation | QILNGGESPKQKGQE HHHCCCCCCHHHCCH | 40.44 | 19664994 | |
229 (in isoform 2) | Phosphorylation | - | 40.44 | - | |
240 | Phosphorylation | KGQEIKRSSGDVLET HCCHHHHCCCCHHHH | 33.40 | 23403867 | |
241 | Phosphorylation | GQEIKRSSGDVLETF CCHHHHCCCCHHHHH | 42.94 | 23403867 | |
247 | Phosphorylation | SSGDVLETFNFLENA CCCCHHHHHHHHHCC | 21.51 | 23403867 | |
257 (in isoform 2) | Phosphorylation | - | 43.37 | - | |
257 | Phosphorylation | FLENADDSDEDEEND HHHCCCCCCCCHHCC | 43.37 | 26503892 | |
293 | Phosphorylation | EGLAADLTDDPDTEE CCCCCCCCCCCCHHH | 38.61 | 30576142 | |
298 | Phosphorylation | DLTDDPDTEEALKEF CCCCCCCHHHHHHHC | 40.90 | 25338102 | |
322 (in isoform 2) | Phosphorylation | - | 45.80 | 21712546 | |
322 | Phosphorylation | EGAGEARSSGDGTEW CCCCCCCCCCCCCCC | 45.80 | 26434776 | |
323 (in isoform 2) | Phosphorylation | - | 35.04 | 25159151 | |
323 | Phosphorylation | GAGEARSSGDGTEWD CCCCCCCCCCCCCCC | 35.04 | 26434776 | |
327 (in isoform 2) | Phosphorylation | - | 38.35 | 28348404 | |
327 | Phosphorylation | ARSSGDGTEWDKDDL CCCCCCCCCCCHHHC | 38.35 | 26434776 | |
335 | Phosphorylation | EWDKDDLSPTAEVWD CCCHHHCCCCCEEEE | 27.48 | 28192239 | |
337 | Phosphorylation | DKDDLSPTAEVWDVD CHHHCCCCCEEEECC | 31.88 | 28450419 | |
337 (in isoform 2) | Phosphorylation | - | 31.88 | - | |
349 | Phosphorylation | DVDQGLISKLKEQYK ECCHHHHHHHHHHHH | 36.66 | 24719451 | |
355 | Phosphorylation | ISKLKEQYKKERKGK HHHHHHHHHHHHCCH | 25.72 | 26657352 | |
374 | Phosphorylation | RANRTKLYDMIADLG HHHHHHHHHHHHHHC | 12.67 | 28796482 | |
390 (in isoform 2) | Phosphorylation | - | 41.86 | - | |
396 | Phosphorylation | PSGIINQSRSASTRM CCCHHCCCCCCCCCC | 24.58 | 27135362 | |
421 | Phosphorylation | AEPITFPSGGGKSFI CCCCCCCCCCCCEEE | 45.97 | - | |
427 | Ubiquitination | PSGGGKSFIMGSDDV CCCCCCEEEECCHHH | 5.20 | 27667366 | |
455 | Phosphorylation | TVTNDADYSYDLPAN EECCCCCCCCCCCCC | 15.73 | - | |
457 | Phosphorylation | TNDADYSYDLPANKD CCCCCCCCCCCCCHH | 18.44 | - | |
464 | Ubiquitination | YDLPANKDAFRKTWN CCCCCCHHHHHHHCC | 51.23 | 27667366 | |
468 | Acetylation | ANKDAFRKTWNPKYT CCHHHHHHHCCCCCC | 51.98 | 18603013 | |
474 | Ubiquitination | RKTWNPKYTLRSHFD HHHCCCCCCHHHHCC | 16.56 | 27667366 | |
474 | Phosphorylation | RKTWNPKYTLRSHFD HHHCCCCCCHHHHCC | 16.56 | 23312004 | |
475 | Phosphorylation | KTWNPKYTLRSHFDG HHCCCCCCHHHHCCC | 23.09 | 24719451 | |
511 | Ubiquitination | LKLWNLQKTVPAKKS EEEEEEECCCCCCCC | 55.44 | 27667366 | |
512 | Phosphorylation | KLWNLQKTVPAKKSA EEEEEECCCCCCCCC | 20.82 | 21406692 | |
518 | Phosphorylation | KTVPAKKSASLDVEP CCCCCCCCCCCCCEE | 23.53 | 21406692 | |
520 | Phosphorylation | VPAKKSASLDVEPIY CCCCCCCCCCCEEEE | 31.99 | 21406692 | |
527 | Phosphorylation | SLDVEPIYTFRAHIG CCCCEEEEEEEECHH | 15.56 | 28152594 | |
528 | Phosphorylation | LDVEPIYTFRAHIGP CCCEEEEEEEECHHC | 13.83 | 21406692 | |
603 | Phosphorylation | GIKNQLLSCSADGTV CHHHCEEECCCCCCE | 18.02 | 21406692 | |
605 | Phosphorylation | KNQLLSCSADGTVRL HHCEEECCCCCCEEC | 26.47 | 21406692 | |
609 | Phosphorylation | LSCSADGTVRLWNPQ EECCCCCCEECCCCC | 11.73 | 21406692 | |
689 | Phosphorylation | NHINRVVSHPTLPVT CCCCCEECCCCCCEE | 22.38 | 23312004 | |
692 | Phosphorylation | NRVVSHPTLPVTITA CCEECCCCCCEEEEE | 37.97 | 23312004 | |
703 | Methylation | TITAHEDRHIKFFDN EEEECCCCCEEEEEC | 30.37 | 115916825 | |
712 | Phosphorylation | IKFFDNKTGKMIHSM EEEEECCCCHHHHHH | 48.57 | 26074081 | |
718 | Phosphorylation | KTGKMIHSMVAHLDA CCCHHHHHHHHHHHH | 12.20 | 26074081 | |
727 | Phosphorylation | VAHLDAVTSLAVDPN HHHHHHHHEEEECCC | 21.53 | 26074081 | |
728 | Phosphorylation | AHLDAVTSLAVDPNG HHHHHHHEEEECCCC | 14.03 | 26074081 | |
737 | Phosphorylation | AVDPNGIYLMSGSHD EECCCCEEEECCCCC | 9.57 | 26074081 | |
740 | Phosphorylation | PNGIYLMSGSHDCSI CCCEEEECCCCCCEE | 34.25 | 26074081 | |
742 | Phosphorylation | GIYLMSGSHDCSIRL CEEEECCCCCCEEEE | 14.62 | 26074081 | |
755 | Acetylation | RLWNLDSKTCVQEIT EEEECCCCHHHHHHH | 45.68 | 25953088 | |
771 | Phosphorylation | HRKKLDESIYDVAFH HHHHHHHHHHHHHHH | 26.56 | 28270605 | |
773 | Phosphorylation | KKLDESIYDVAFHSS HHHHHHHHHHHHHCC | 17.40 | 28270605 | |
779 | Phosphorylation | IYDVAFHSSKAYIAS HHHHHHHCCCHHHHH | 27.38 | 27251275 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of STRN3_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of STRN3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of STRN3_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-229 AND SER-257, ANDMASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-229, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-229 AND SER-257, ANDMASS SPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-229, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-229, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-229, AND MASSSPECTROMETRY. |